SNDX - Syndax Pharmaceuticals GAAP EPS of -$0.62 August, 08 2022 04:36 PM Syndax Pharmaceuticals Inc. Syndax Pharmaceuticals press release ( NASDAQ: SNDX ): Q2 GAAP EPS of -$0.62. As of June 30, 2022, Syndax had cash, cash equivalents, short-term and long-term investments of $378.9 million For further details see: Syndax Pharmaceuticals GAAP EPS of -$0.62